Merck, Schering initiate campaign to defend Vytorin, Zetia

04/1/2008 | Wall Street Journal (free content), The

Schering-Plough Corp. and Merck & Co. are stepping up efforts to promote Vytorin and Zetia after a panel of cardiologists recommended limiting the use of the cholesterol treatments. The companies reportedly plan to resume direct-to-consumer advertising and approach managed care plans and pharmacy-benefit managers.

View Full Article in:

Wall Street Journal (free content), The

Published in Brief:

SmartBrief Job Listings for Media

Job Title Company Location
Senior Manager, Marketing
IAB
New York, NY
VP, Membership Sales
Mobile Marketing Association (MMA)
New York, NY
Director Business and Legal Affairs
The Weather Channel
Atlanta, GA
Director, Industry Initiatives (Digital Video and AdvancedTV)
Interactive Advertising Bureau
New York, NY
Sr. Product Marketing Manager
TRUSTe
San Francisco, CA